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Colon cancerCurrently, there is signiﬁcant interest in the ﬁeld of diet–gene interactions and the mechanisms by which
food compounds regulate gene expression to modify cancer susceptibility. From a nutrition perspective,
two key components potentially exert cancer chemopreventive effects: isothiocyanates (ITCs), present in
cruciferous vegetables, and selenium (Se) which, as selenocysteine, is an integral part of selenoproteins.
However, the role of these compounds in the expression of key selenoenzymes once the cancer process
has been initiated still needs elucidation. Therefore, this investigation examined the effect of two forms of se-
lenium, selenium-methylselenocysteine and sodium selenite, both individually and in combination with two
ITCs, sulforaphane or iberin, on the expression of the two selenoenzymes, thioredoxin reductase 1 (TrxR1)
and gastrointestinal glutathione peroxidase (GPx2), which are targets of ITCs, in Caco-2 cells. Co-treatment
with both ITCs and Se induced expression of TrxR1 and GPx2 more than either compound alone. Moreover,
pre-treatment of cells with ITC+Se enhanced cytoprotection against H2O2-induced cell death through a
ROS-dependent mechanism. Furthermore, a single and double knockdown of TrxR1 and/or GPx2 suggested
that both selenoproteins were responsible for protecting against H2O2-induced cell death. Together, these
data shed new light on the mechanism of interactions between ITC and Se in which translational expression
of the enhanced transcripts by the former is dependent on an adequate Se supply, resulting in a cooperative
antioxidant protective effect against cell death.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The association between intakes of fruit and vegetables, and the
risk of colon cancer is complex and has been the focus of a large num-
ber of epidemiological studies; however, to date the results have been
inconsistent [1]. Given the nature of tumour biology and the multiple
mechanisms involved in colon carcinogenesis [2], it has been widely
recognised that there may be advantages in combining a variety of
food constituents since their complementary mechanisms of action
may prevent the accumulation of alterations during neoplastic trans-
formation that lead to uncontrolled cell growth and loss of genomic
stability. Since sulforaphane (SFN) has been shown to induce two
selenoenzymes, thioredoxin reductase 1 (TrxR1) and gastrointestinal
glutathione peroxidase (GPx2), both SFN and selenium have been
proposed as partners in cancer prevention [3]. However, both
selenoenzymes have been shown to be up-regulated during cancer
progression [4,5]. In addition, there is solid evidence indicating that+44 1603 591750.
l rights reserved.the NF-E2-related factor 2 (Nrf2) is involved in colon tumorigenesis
[6], and considering that the promoter regions of both selenoproteins
contain an antioxidant response element (ARE) that is regulated by
Nrf2, it makes them an obvious target of study.
Investigating the consequences of altering the levels of Nrf2 and
its associated cytoprotective genes, such as TrxR1 and GPx2, by
isothiocyanates (ITCs) and their glucosinolate precursors is important
because these natural compounds suppress the initiation of a wide
range of carcinogen-induced tumours in rodents and also because
they can be present in signiﬁcant amounts in the human diet [7,8].
ITCs inﬂuence the process of carcinogenesis partly by modulation of
phase I and II enzymes, induction of apoptosis and cell cycle arrest
[9,10]. The fact that SFN metabolites have been detected in all tissues
with the highest concentration in the small intestine, colon and pros-
tate [11], has led to the view that they can potentially be used for the
prevention of cancer [12,13]. However, further studies are needed
since Nrf2 may take on a pro-tumoral identity in cancerous cells.
Selenium (Se) is another dietary compound that has been shown
to have cancer-chemopreventive roles. A large body of experimental
evidence in animal and cell culture models indicates that this
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mechanisms, including altered carcinogen metabolism, cell cycle reg-
ulation, immune surveillance, cell death programming, cancer cell
migration and angiogenesis [14,15]. Some of these functions may be
linked to the crucial fact that Se is a component of the amino acid
selenocysteine, which is incorporated into 25 genes encoding over
30 mammalian selenoproteins [16]. In addition, there is extensive
evidence that monomethylated forms of Se are critical metabolites
for the chemopreventive effect of Se [17] and experimental evidence
suggests that any precursor that will directly generate a steady
stream of methylselenol (CH3SeH) or its derivative, is more active
than selenite or selenomethionine in tumour inhibition [18,19]. How-
ever, conﬂicting ﬁndings from clinical trials investigating the possible
use of selenium as an anti-carcinogen [20] indicates that a more fo-
cused approach is needed to understand the mechanisms of different
forms of Se on antioxidant and anticancer activity.
Studies employing different forms of Se and/or ITCs might provide
further clues to understand better the potential risks and beneﬁts of al-
tering the level of TrxR1 and GPx2 in a cancer cell model. Therefore, the
current studywas conducted to understand the direct effect of two ITCs,
SFN and iberin, in combination with Se-methylselenocysteine (SeMSC)
or sodium selenite and to establish whether a combination of these
dietary components exerts additive or synergistic effects on the regula-
tion of TrxR1 and GPx2 in human colon adenocarcinoma Caco-2 cells.
Moreover, the role of ITC+Se in protecting cells from H2O2-mediated
cytotoxicity and the contribution made by TrxR1 and/or GPx2 in pro-
moting the survival of colon cancer cells were also investigated.
2. Material and methods
2.1. Reagents
SFN and iberin was purchased from ENZO Life Sciences (UK).
Seleno-methylselenocysteine was obtained from Eburon Organics
(Belgium). Complete protease inhibitors and cell proliferation
reagent WST-1 were purchased from Roche Applied Science (UK).
Rabbit polyclonal primary antibodies to TrxR1, Nrf2, Sam68, goat
polyclonal primary antibody to β-actin and horseradish peroxidase
(HRP)-conjugated goat anti-rabbit and/or rabbit anti-goat IgG as sec-
ondary antibodies were all obtained from Santa Cruz Biotechnology
(Santa Cruz, USA). As primary antibody for GPx2, rabbit anti-human
antiserum was used [21]. Electrophoresis and Western blotting sup-
plies were supplied by Bio-Rad (UK), and the enhanced chemilumi-
nescence (ECL) kit was purchased from GE Healthcare (Little
Chalfont, UK). Nrf2 small interfering RNA (siRNA) was supplied by
Applied Systems (UK). TrxR1, GPx2, AllStars Negative Control siRNA
and HiPerFect transfection reagent were all obtained from Qiagen
(West Sussex, UK). 5-(and-6)-carboxy-2′,7′-dichlorodihydroﬂuorescein
diacetate, acetyl ester (CM-H2DCFDA) was purchased from Invitrogen,
Molecular Probes, USA. Sodium selenite, dimethylsulfoxide (DMSO),
hydrogen peroxide (H2O2), Bradford reagent, RT-PCR primers and
probes used, and all other chemicals were obtained from
Sigma-Aldrich (UK), unless otherwise stated.
2.2. Cell culture
The human colon adenocarcinoma cell line, Caco-2, was purchased
from the American Type Culture Collection (Middlesex, UK). Cell culture
media and supplements were bought from Invitrogen (Paisley,
Scotland), except for foetal bovine serum (FBS) which was obtained
from Biosera, UK. Caco-2 cells were cultured in Dulbecco's Modiﬁed
Eagle's Medium (DMEM), supplemented with 10% (v/v) heat-
inactivated FBS, 1% (v/v) of L-glutamine (200 mM) and 1% (v/v) antibi-
otic solution consisting of penicillin (5000 units/ml), streptomycin
(5000 μg/ml). The DMEM used in this study is a Se-free medium;
however, under normal cell culture conditions FBS is a major sourceof selenium. The selenium content of the FBS used in this study was
13 μg/l (equivalent to a ﬁnal concentration of 16 nM Se when 10%
of FBS is added to the cell culture medium) as determined by Biosera
(UK). Experimental cells were seeded in six-well plates at
6×104cells/well in a ﬁnal volume of 3 ml and were supplemented
with ITCs and/or Se when conﬂuence reached ~70% (usually after
3 days). For time course experiments, all the different groups were
treated at the same time and harvested at appropriate intervals. All
treatments and controls contained a ﬁnal DMSO concentration of
0.05% (v/v).
2.3. Cell proliferation assay
The WST-1 cell proliferation assay was used to detect the toxicity
of ITC (1–100 μM), selenium (0.2–100 μM) and H2O2 (200–800 μM)
in Caco-2 cells. The assay was performed in 96-well plates when
cells were at approximately 60-70% conﬂuence according to the
manufacturer's instruction (Roche Applied Science). The intensity of
the coloured compound formed (formazan dye) was then quantiﬁed
using a micro plate reader (BMG Labtech Ltd, UK). The absorbance
was measured at 450 nm, with the reference at 630 nm. Cell prolifer-
ation of treated cells was expressed as a percentage of control as
follows: (A450 nm−A630 nm) sample/(A450 nm−A630 nm) con-
trol×100. The IC50 was determined using CalcuSyn software Version
2.0 (Biosoft, Cambridge, UK).
2.4. Real-time PCR
Total RNAwas extracted from Caco-2 cells using GenElute™ Total
Mammalian RNA kit (Sigma, UK) according to the manufacturer's in-
struction. First strand cDNA was synthesised with 1 μg of total RNA
using qScript cDNA SuperMix (Quanta BioSciences, USA). TrxR1
and GPx2 mRNA quantiﬁcation was determined by TaqMan using
the ABI 7500 Fast Real-Time PCR System (Applied Biosystems, War-
rington, UK). Primers and ﬂuorogenic TaqMan probes were designed
using Primer Express® Software (Applied Biosystem, UK) based on
their human sequences. The probes were labelled with a 5′ reporter
dye, FAM (6-carboxyﬂuoroscein) and 3′ quencher dye, TAMRA
(6-carboxytetramethylrhodamine). Real-time PCR reactions were
carried out using Precision™ MasterMix (Primer Design, UK) and
samples were run following a 10 min hot start at 95 °C, followed
by 40 cycles of denaturing at 95 °C for 15 s and annealing/extension
at 60 °C for 60 s. The following primer pairs were used for quantitative
PCR: TrxR1 forward 5′-CCACTGGTGAAAGACCACGTT-3′, reverse
5′-AGGAGAAAAGATCATCACTGCTGAT-3′, probe 5′-CAGTATTCTT
TGTCACCAGGGATGCCCA-3′; GPx2 forward 5′-CACACAGATCTC
CTACTCCATCCA-3′, reverse 5′-GGTCCAGCAGTGTCTCCTGAA-3′,
probe 5′-CATGCTGCATCCTAAGGCTCCTCAGG-3′; 18S rRNA forward
5′-GGCTCATTAAATCAGTTATGGTTCCT-3′, reverse 5′-GTATTAGCTCTAGA
ATTACCACAGTTATCCA-3′, probe 5′-TGGTCGCTCGCTCCTCTCCCA-3′. Data
were normalised against an invariant endogenous control, 18S ribosom-
al RNA. The threshold cycle number (Ct) obtained was converted into
fold of relative induction using the ΔΔCt method [22].
2.5. Protein extraction
Total proteins from Caco-2 cells were extracted by washing cells
twice with ice-cold PBS and treating them for 5 min with 100 μl of
ice-cold cell lysis buffer containing Tris-EDTA buffer pH 8.0 (20 mM
Tris, 2 mM EDTA), 150 mM NaCl, 10% glycerol, 1% Nonidet P-40 and
mini complete proteinase inhibitor, before the cells were collected
by the use of a rubber policeman. Thereafter the lysates were placed
in an Eppendorf tube and incubated on ice for 15 min (vortexing
the samples 3 times at full speed during incubation) with a ﬁnal cen-
trifugation step at 13,000 g for 10 min to collect the supernatants.
Nuclear and cytoplasmic protein extracts were also obtained by
1916 L.N. Barrera et al. / Biochimica et Biophysica Acta 1823 (2012) 1914–1924using NE-PER nuclear and cytoplasmic extraction reagents (Pierce,
Rockford, IL) according to the manufacturer's instructions. Protein
concentrations were determined by the Bradford protein assay
using BSA as a standard.
2.5.1. Western blot analysis
Equivalent amounts of protein (40 μg) were mixed with loading
buffer and heated at 95 °C for 5 min to be size fractioned in 12%
SDS-PAGE prior to transfer to an Immun-Blot polyvinylidene
diﬂuoride membrane using a Trans-Blot semi-dry transfer system.
The membrane was blocked for 1 h at room temperature with 5%
(w/v) non-fat milk in PBST, followed by incubation with primary an-
tibody in the same solution at 4 °C overnight. Membranes were
washed with PBST, three times for 10 min each, and incubated with
HRP-conjugated secondary antibody for 1 h at room temperature.
The membranes were then washed three times with PBST for
10 min each, and developed with an ECL system and visualised
using a LAS-3000 Fujiﬁlm intelligent dark box. The illuminated
bands were detected and the image captured using Image Reader
LAS-3000 software. Densitometric analysis of the Western blot was
performed using Quantity One® Ver. 4.6.3 basic software (Bio-Rad
Laboratories, UK). Results were normalised against β-actin to correct
for protein loading, and the protein expression from the different
treatments was calculated relative to the control.
2.6. ITC- and/or Se-mediated cytoprotection in Caco-2 cells
The protective effects of ITCs and/or Se against H2O2-induced
cytotoxicity was investigated. Caco-2 cells (7×103cells/well in a
96-well plate) were grown for 48 h before media was removed and
cells treated with 100 μl of DMEM containing the vehicle (DMSO),
SFN (6 μM), sodium selenite (50 nM), and a combination of ITC+Se
using 12 replicates per treatment. After 24 h, a stock solution of
H2O2 was diluted with serum-free media, to avoid the possibility
that serum components might differentially affect the results [23],
to a ﬁnal concentration of 500 μM before the media was removed
from the cells; 6 replicates were treated with 100 μl of this solution
and the remaining 6 with an equal amount of the vehicle (water).
After 24 h cell proliferation was measured using WST-1 cell prolifer-
ation assay.
2.7. Effects of TrxR1, GPx2 and Nrf2 knockdown on H2O2-mediated cell
death
A single (TrxR1, GPx2, Nrf2) and a double (TrxR1/GPx2) knock-
down approach was used to investigate the effect of these proteins
on cell protection when cells are pre-treated with SFN+Selenite
and challenged with H2O2. In summary, on the day of transfection
Caco-2 cells were seeded at 1.8×104cells/well of a 96-well plate in
170 μl of 10% FBS DMEMmedium (containing L-glutamine and antibi-
otics). To prepare the transfection complexes of the single and double
knockdown treatments, stock solutions of Nrf2, TrxR1 and/or GPx2
siRNA and AllStars negative control siRNA were diluted in 30 μl of
plain DMEM, followed by addition of HiPerFect and a 10-min incuba-
tion period before being gently added drop-wise to the cells (to give a
ﬁnal siRNA concentration of 50 nM after adding complexes to cells
seeded in 170 μl DMEM). In order to guarantee that the single and
double knockdown treatments contained an identical ﬁnal siRNA
concentration, individual siRNAs (25 nM) from the former was
mixed with AllStars negative control siRNA (25 nM). After 24 h incu-
bation with siRNA, the medium was removed and 100 μl of DMEM
containing SFN+selenite added for a further 24 h. The medium was
removed again and serum-free media containing 500 μM of H2O2
added for 24 h; cell proliferation was measured using the WST-1
cell proliferation assay.2.8. Reactive oxygen species measurement
To measure the effect of SFN and/or selenite on reactive oxygen
species (ROS) production, as well as their effect after knocking
down TrxR1 and GPx2, Caco-2 cells were plated at 7×105/well in a
24 well plate and cells were either left untransfected or transfected
with siRNA, respectively, and treated with SFN+selenite as described
in the previous section. After 24 h incubation with SFN+selenite the
medium was removed and cells were washed and incubated for
40 min in PBS containing 1 μM of the ﬂuoroprobe CM-H2DCFDA.
PBS was discarded and cells were incubated with 500 μM of H2O2 di-
luted in PBS for 1 h. Subsequently, the media was discarded and cells
collected, centrifuged, washed and re-suspended in 100 μl PBS. Intra-
cellular ROS production was determined by detection of ﬂuorescent
intensity of the oxidised product 2′,7′-dichloroﬂuorescein in the
FL1-A channel with the BD Accuri C6 ﬂow cytometer.
2.9. Assessment of apoptosis and cell death
The effect of siRNA on Caco-2 cells apoptosis was assessed using
an Annexin V-FITC apoptosis detection kit, from eBioscience,
according to the manufacturer's instructions. Caco-2 cells were
trypsinised and collected, including ﬂoating apoptotic cells and the
cells spontaneously detached during washing procedure. Annexin
V-FITC (ﬂuorescein isothiocyanate) was used to stain for the apopto-
tic cells, and propidium iodide (PI) used to stain the necrotic cells.
Flow cytometry for measuring apoptosis was performed with the
BD Accuri C6 ﬂow cytometer.
3. Statistical methods
Statistical analyseswere carried out using the SPSS 16 statistical pro-
gram. Results are expressed as means±SD. Statistical comparisons
were made using Student's t-test and one-way ANOVA with Dunnett's
post‐hoc test when treatment samples were compared only against
the control group and with Bonferroni's post‐hoc test when compari-
sons between groups were made. For Western blotting experiments,
data are representative of two independent experiments.
4. Results
4.1. Effect of isothiocyanates and selenium on cell survival
Caco-2 cells were exposed to a range of concentrations of ITCs
(1–100 μM) and Se (0.2–100 μM) for 24 or 48 h to evaluate cytotox-
icity. Concentrations of SFN and iberin above 12 μM reduced cell
growth signiﬁcantly in a time- and dose-dependent manner (Fig. 1A
and B). The IC50 values for SFN were 31.6 (24 h) and 20.5 μM
(48 h), and for iberin were 42.3 (24 h) and 22.7 μM (48 h). These re-
sults are in agreement with published data using different cytotoxic-
ity assays [24–26].
Regarding the cell response after Se treatment, Fig. 1C shows an
increase of 20–30% in cell growth after treating cells with 0.2–10 μM
of selenite for 24 or 48 h. However, decreased cell proliferation was
observed when cells were treated with concentrations above 50 μM
for 48 h (Fig. 1C). In relation to SeMSC, a similar increase in cell prolif-
erationwas observed, but no toxicity was reportedwith concentrations
up to 100 μM (Fig. 1D). This increase in cell number agrees with other
data in which increased cell proliferation after Se treatment at concen-
trations in the nanomolar to micromolar range was detected in Caco-2,
HRT18 and HT-29 [27].
Based on these data and taking into consideration other studies,
the concentrations used for further experiments were between 3 to
12 μM for ITC and 25 to 200 nM for Se. ITC concentrations in this
range may be achieved in human plasma by consumption of
ITC-rich vegetables or high glucosinolate broccoli [28,29].
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Fig. 1. The effect of (A) sulforaphane, (B) iberin, (C) selenite and (D) SeMSC on Caco-2 cells as measured by cell metabolic assay WST-1. Caco-2 cells were treated for up to 48 h with
DMSO (control) or with the indicated concentrations of ITCs or selenium, and cell cytotoxicity was evaluated. Data (optical density) represent the mean±SD of six replicates
expressed as percentage of control. Signiﬁcant differences from control are indicated (*Pb0.05; **Pb0.01; ***Pb0.001). Lines drawn on the graph indicate that all the bars included
within the line are signiﬁcantly different from their corresponding control group.
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TrxR1 and GPx2 are two important redox-modulating enzymes
that have been suggested to play an important role during inﬂamma-
tion and cancer [30,31]. The time course effect of ITCs on TrxR1 and
GPx2 gene expression after exposing Caco-2 cells to 6 μM of SFN
and iberin from 4 to 48 h was investigated to provide information
about the regulation of mRNA over time. The results showed a signif-
icant increase in expression of TrxR1 and GPx2 after treatment with
SFN or iberin in a time- dependent manner compared to control,
with a peak induction of 4.5-fold at 12 h for TrxR1 and a peak of
~3.5-fold at 24 h for GPx2 (Fig. 2A and B). The TrxR1 mRNA returned
to basal levels after 48 h but only declined slightly for GPx2, which
implies that the mRNA turnover rate is different for each transcript.0
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Fig. 2. Time- and dose-dependent effect of ITCs on mRNA expression. Caco-2 cells were expo
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4.3. Cooperative effects of ITC and Se in the up-regulation of TrxR1 and
GPx2
The effect of selenite and SeMSC on levels of TrxR1 and GPx2
mRNA expression, either alone or in combination with SFN and/or
iberin, were investigated (Fig. 3A and B). The level of TrxR1 or GPx2
mRNA was not increased by either form of Se within 48 h. However,
the combination of iberin and selenite increased TrxR1 expression
by 41% after 8 h compared to that of iberin alone (Pb0.05), but no
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duced by SFN alone after 24 h or SFN+Se at 8 or 24 h. After 24 h an
increase of ~29% was observed when iberin was added with either
selenite or SeMSC (Pb0.05) (Fig. 3A).
Although an additive effect of TrxR1 mRNA was not observed
when SFN was added with either form of Se, a comparable trend
was seen, especially at 8 h. TrxR1 mRNA expression decreased after
48 h, with only SFN+SeMSC remaining 2-fold higher over the con-
trol and still larger than observed in the presence of only SFN
(Fig. 3A). The maximum increase of TrxR1 mRNA was detected with
SFN+SeMSC at 24 h with a peak of 4.3-fold. This peak was signiﬁ-
cantly higher than for iberin+SeMSC treated cells (Pb0.01).
In a similar manner, GPx2 mRNA was induced ~2-fold after treat-
ment with either ITC (8 h) and was increased to 3- and 4-fold at 24 h
for iberin and SFN, respectively, (Pb0.001) (Fig. 3B). However, addi-
tion of selenium had no signiﬁcant effect on GPx2 mRNA expressionTrxR1
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Fig. 4. Differential levels of TrxR1 protein expression in Caco-2 cells following supplementa
were harvested and equal amounts of proteins (40 μg) were resolved by SDS/10% PAGE forW
55 kDa and densitometric analysis of these bands were normalized to β-actin signal (42 kD
tative of two independent experiments.when compared to either ITC alone. To determine whether mRNA
induction of these two selenoproteins was translated into protein,
Caco-2 cells were treated for 48 h with different concentrations of
ITCs and/or Se (Figs. 4A, B and 5A, B) over 8, 24 and 48 h (Figs. 4C
and 5C). The resulting proteins were extracted and quantiﬁed by
Western blot analysis.
ITC treatment did not up-regulate the expression of the two
selenoproteins at the protein level as was observed at the mRNA
level. The TrxR1 protein induction patterns observed with ITC+Se
(Fig. 4) correlated comparatively well with the mRNA level in
Fig. 3A. This is different to the GPx2 protein pattern (Fig. 5) which dif-
fered clearly from that obtained at the mRNA level (Fig. 3B). However,
both selenoproteins showed a similar pattern of induction at the
protein level.
The data presented here suggest that Se is the limiting nutrient
determining the overall additive effect at the protein level when0 3.0 4.2 6.6 1.0 3.3 5.7 4.9
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Fig. 5. Differential levels of GPx2 protein expression in Caco-2 cells following supplementation of ITCs and/or Se for 48 h (A and B) and for 8, 24, and 48 h (C). Whole-cell lysates
were harvested and equal amounts of proteins (40 μg) were resolved by SDS/10% PAGE for Western blot analysis. The translated GPx2 product appeared as a band of approximately
22 kDa and densitometric analysis of these bands was normalized to β-actin signal (42 kDa) and was converted into fold of induction relative to control=1. Data are representative
of two independent experiments.
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(Figs. 4A and 5A). After comparing ITCs, SFN appeared to bemore ef-
fective in inducing mRNA, as reﬂected by a higher protein synthesis
(Figs. 4B and 5B).
Regarding the form of Se used, although iberin+selenite led to a
maximum peak of TrxR1 protein at 24 h (6.6-fold) (Fig. 4C), the
same treatment decreased protein synthesis to 4.9-fold after 48 h,
whereas the iberin+SeMSC treatment resulted in a subtle increase
from 4.2- (24 h) to 5.7-fold (48 h). In relation to GPx2, it was also
observed that Caco-2 cells supplemented with iberin+SeMSC
sustained a more prolonged increase in protein expression than did
iberin+selenite, increasing from 8.4-fold (24 h) to 17-fold (48 h)
for the former (Fig. 5C).
4.4. Nrf2 translational expression pattern in ITC and/or Se treated Caco-2
cells
The underlying mechanisms by which ITC+Se up-regulate further
gene expression of intracellular antioxidants need to be addressed. In
order to identify whether the mechanisms involved in the induction
of antioxidant enzymes when Caco-2 cells are co-treated with ITCs
and selenium is also Nrf2 dependent, cytosolic and nuclear protein
extracts were studied in Caco-2 cells treated with ITCs+Se to establish
the role of this important nuclear factor in the reported cooperative
effect of TrxR1 and GPx2.β-Actin
Nrf2
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Selenite (200 nM) - + - - + - - + -
SeMSC (200 nM) - - + - - + - - +
SFN (6 µM) - - - + + + - - -
Iberin (6µM) - - - - - - + + +
Cytosol 
Fig. 6. Representative images of Nrf2 immunoblots with cytosolic and nuclear fractions deriv
or iberin+Selenium. Cellular fractions (30 μg) were resolved by SDS/10% PAGE. Cytosolic an
respectively and bands were seen at 57- (cytosol) and ~110-kDa (nuclear). Densitometric an
(68 kDa) signals respectively and results were converted into fold of induction relative to cITC treatment clearly enhanced Nrf2 in the nucleus (Fig. 6). As
expected, exposure to SFN or iberin for 8 h increased nuclear Nrf2
by 3-fold accompanied by a concomitant decrease of Nrf2 in the cyto-
sol (Fig. 6). However, translocation was not inﬂuenced by Se.
4.5. ITC and/or Se-mediated cytoprotection in Caco-2 cells
As co-treatment of ITCs and Se resulted in the cooperative induc-
tion of TrxR1 and GPx2 in a time- and dose- dependent manner, a
study was conducted into whether these increases were correlated
with protection of cells against oxidative stress insult. Cells were
pre-treated with SFN (6 μM) and/or selenite (50 nM) for 24 h
followed by treatment with 500 μM H2O2. Sulforaphane and selenite
were selected as they induced greater expression of TrxR1 and GPx2
in previous experiments. The cytotoxic effect of H2O2 was evaluated
by treating Caco-2 cells with increasing concentrations of H2O2, rang-
ing from 200 to 800 μM. Doses of H2O2 above 200 μM evoked a highly
signiﬁcant decrease in cell proliferation, with an IC50 value of 503 μM
(Supplementary Fig. 1). This decrease in proliferation was reduced by
35% (Pb0.001) and 20% (Pb0.001) after 24 h pre-treatment with sel-
enite and SFN, respectively, (Fig. 7A). Interestingly, co-treatment with
SFN+selenite signiﬁcantly abolished H2O2-induced cell damage, an
observation which was conﬁrmed using an annexin V/propidium io-
dide apoptosis assay (Fig. 7C and D). Results were conﬁrmed by
staining cells with propidium iodide only (Supplementary Fig. 2). In1.0 1.0 1.0 2.8 3.0 3.0 3.1 3.2 3.2
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Fig. 7. Effect of ITCs and/or selenium on (A) cell proliferation, (B) ROS and (C, D) cell viability in Caco-2 cells. (A) Caco-2 cells were pre-incubated for 24 h with DMSO, SFN (6 μM)
and/or selenite (50 nM) before exposure to vehicle (H2O) or H2O2 (500 μM) in serum-free medium for 24 h. Cell proliferation was measured by WST-1 assay. SFN and/or
selenite-mediated cytoprotection are shown in grey bars as a percentage of the H2O2 untreated group (black bars). Results are mean±SD of six replicates. (B) Caco-2 cells were
pre-incubated with SFN and Se as speciﬁed above, followed by incubation with 1 μM CM-H2DCFDA for 45 min. Then, cells were washed and incubated with H2O2 (500 μM) for
1 h. Cells were then assessed for H2DCFDA oxidation using ﬂow cytometer. Results are mean±SD of duplicates. (C) Caco-2 cells were pre-incubated for 24 h with DMSO, SFN
(6 μM) and/or selenite (50 nM) before exposure to vehicle (H2O) or H2O2 (500 μM) in serum-free medium for 1 h, following apoptosis detection by ﬂow cytometry analysis of
Annexin V/PI staining. (D) Results as in C for two different experiments are shown. Data represent viable Caco-2 cells (Annexin V-negative and propidium iodide-negative).
Signiﬁcant differences from control and between treatments are indicated (*Pb0.05; **Pb0.01; ***Pb0.001).
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exerted through regulation of redox equilibrium, the levels of reactive ox-
ygen species (ROS) were assessed. H2DCFDA oxidation was reduced
when cells were pre-treated with Se, SFN and SFN+Se by 17%, 32%
(Pb0.01) and 50% (Pb0.001), respectively, (Fig. 7B).
4.6. Effect of TrxR1/GPx2 or Nrf2 knockdown on H2O2-induced cell death
and ROS levels
To investigate whether TrxR1/GPx2 and Nrf2 are the main genes by
which ITCs and Se protect against H2O2-induced cell death in Caco-2
cells, a single and double knockdown approach was used to suppress
the expression of the aforementioned selenoproteins and transcriptional
factor. The knockdown efﬁciency showed an 80% reduction in expression
of TrxR1 and GPx2 and 73% reduction in the expression Nrf2 (Fig. 8A–C).
Addition of 500 μMof H2O2 in control cells transfected with AllStars neg-
ative control, without pre-treatmentwith SFN or Se, decreased cell prolif-
eration by 60% (Pb0.001) (Fig. 8D). In contrast, cells transfected with
AllStars negative control but after pre-treated with SFN+Selenite, were
100% viable after addition of H2O2, conﬁrming the level of protection ob-
served in Fig. 7A. After a single knockdown with either TrxR1- or
GPx2-siRNA, prior to a pre-incubation step with SFN+selenite and
followed by an oxidative stress challenge with H2O2, the levels of protec-
tion were reduced by 18% and 27.5% (Pb0.01), respectively, (Fig. 8D). In-
terestingly, when both selenoproteins were knocked down together a
57% reduction in cell proliferation (Pb0.001) was observed, equivalentto that obtained in the control group without SFN+Se pre-treatment.
In addition, after knock down of Nrf2, a 71% (Pb0.001) reduction in cell
proliferationwas observedwhich emphasises the importance of this tran-
scriptional factor in promoting induction of other detoxifying enzymes
apart from TrxR1 and GPx2. Moreover, the knockdown of Nrf2 in cells
without SFN+Se treatment exposed to H2O2 (500 or 600 μM) showed
a similar susceptibility to the control cells (Supplementary Fig. 3). To in-
vestigate whether reduction in cell proliferation is mediated through al-
tered levels of ROS in Caco-2 cells, two of the experimental siRNA
knockdowns (TrxR1 and GPx2) were selected to analyse production of
ROS using H2DCFDA. A reduction in H2DCFDA oxidation was observed
when cells were pre-incubated with SFN+Se without knockdown. In
contrast, a signiﬁcant increase in ROS levels was found after knock
down of TrxR1 (156%) and GPx2 (132%) (Fig. 8E). Additionally, the
viability of Caco-2 cells was analysed after 48 of siRNA transfection by
Annexin V/PI. Cell viability was comparable among the different siRNAs
used with that of control cells, indicating that the response observed
was not due to siRNA toxicity (Supplementary Fig. 4).
5. Discussion
5.1. Transcriptional and translational regulation of GPx2 and TrxR1 in
Caco-2 cells treated with ITCs and/or Se
The present study examined the effect of SFN or iberin, either
individually or in combination with an inorganic (selenite) or organic
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Fig. 8. siRNA knockdown efﬁciency of (A) TrxR1, (B) GPx2 and (C) Nrf2. (D) Cell proliferation effects of TrxR1 and/or GPx2 and Nrf2 knockdown on Caco-2 cells untreated or
pre-treated with SFN+Se followed by incubation with vehicle (H2O) or H2O2, (E) ROS levels effects of TrxR1 or GPx2 knockdown on Caco-2 cells pre-treated with SFN+Se
(A-C) Caco-2 cells were exposed to 1) 50 nM of AllStars negative control siRNA (control); 2) 25 nM of TrxR1 or GPx2 siRNA+25 nM AllStars siRNA (single knockdown); 3)
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siRNA TrxR1 or siRNA GPx2 (single knockdown) as speciﬁed above for 24 h before Caco-2 cells were pre-incubated with SFN and Se for an additional 24 h, followed by incubation
with 1 μM CM-H2DCFDA for 45 min and incubation with H2O2 (500 μM) for 1 h. Cells were then assessed for H2DCFDA oxidation using ﬂow cytometry. Results are mean±SD of
duplicates. Signiﬁcant differences are indicated (*Pb0.05; **Pb0.01; ***Pb0.001).
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major role in controlling redox-regulated processes in colon cells.
The cooperation of ITC and selenite in TrxR1 induction has previously
been reported in human HepG2 cells and hepatocytes [32,33], and
MCF-7 human breast adenocarcinoma cells [34]. Although several
studies have documented the apoptotic effect of different ITCs at
high concentrations [35,36], no studies had compared different ITCs
at relatively low doses in combination with inorganic and organic
forms of Se, and modulation of GPx2 under these conditions have
not been explored in vitro.
By combining ITCs and Se compounds, SFN and selenite were found
to be themost effective combination, eliciting large increases in expres-
sion of TrxR1 and GPx2 than either compound alone after 24 h treat-
ment. Previous studies have shown that selenium-enriched broccoli,
which contains mainly SeMSC did not increase GPx1 activity to the
same extent as selenite or selenomethionine, presumably because the
SeMSC is metabolised directly to methyl selenol and excreted [37].
However, other workers have reported that SeMSC induced GPx1 to a
similar level to selenite in a selenium-deﬁcient Caco-2 cell model [38].
Interestingly, our time-course experiments suggest that SeMSC is able
to maintain a more sustained protein up-regulation than selenite after
48 h for both genes.Activation of ARE facilitates rapid mRNA synthesis which is inde-
pendent of selenium [39,40], whereas translation into the respective
selenoproteins requires Se. Thus, SFN can up-regulate mRNA levels
by induction and Se by stabilisation [32,41,42] pathways. However,
SFN-induced mRNA can only be translated in the presence of ade-
quate levels of Se. This agrees with the results reported here for
TrxR1 and for GPx2, showing that Se is the limiting factor for protein
synthesis from increased ITC-induced mRNA. A recent study showed
that SFN decreased mTOR-S6K1-S6 signalling and inhibited protein
synthesis [43]. The role of mTOR pathway in the expression of
TrxR1 and GPx2 requires further investigation.
Expression and activity of GPx2 and TrxR1 are both regulated by
Se through the selenocysteine insertion mechanism [44]. However,
as observed in this study, selenoprotein expression depends on the
form and concentration of Se, and may also depend on the cell-type
under study. Conversely, this regulation occurs at different levels for
different selenoenzymes, which means that selenoproteins are regu-
lated individually; this might imply a prioritisation of the available
Se so that synthesis of some selenoproteins is maintained over that
of others. From this phenomenon, called hierarchy of selenoproteins,
it has been observed that, under conditions of limited selenium sup-
ply, the mRNA of GPx2 can even increase and become preferentially
1922 L.N. Barrera et al. / Biochimica et Biophysica Acta 1823 (2012) 1914–1924translated when selenium supply is restored [45]. According to its
high ranking in the hierarchy, GPx2 mRNA was not inﬂuenced by
Se, but was increased by ITC independent of Se. This increase was
not further augmented when ITC+Se was added. A similar lack of
expression was observed for TrxR1 mRNA following Se addition.
However, a cooperative effect was observed after adding ITC+Se at
the mRNA level.
This variation among selenoproteins has been found to be a result of
differences in the selenocysteine insertion sequence (SECIS)-binding
protein, SBP2, which is a major determinant in establishing the hierar-
chy of selenoprotein synthesis and selenoprotein mRNA turnover [46].
When UGA decoding is inefﬁcient, as occurs when Se is limiting, termi-
nation occurs at these positions favouring mRNA degradation. This
mechanism, termed nonsense-mediated decay is also considered to be
responsible for the observed induction of TrxR1 and GPx2 in Caco-2
cells after co-addition of ITC+Se; this is considered to be due to a
reduced mRNA degradation rate rather than to over-stimulation of the
Nrf2-ARE signalling pathway when Se is added.
5.2. TrxR1/GPx2 and Nrf2 knockdown in the cooperation between ITC
and Se-mediated cytoprotection
The contribution of oxidative stress towards the aetiology of colon
cancer has been widely recognised. It is well known that incidence of
colon cancer is at least 30-fold higher than that of the small intestine
[47]. In contrast to the latter, the colon is exposed to high levels of su-
peroxide radicals (O2•ˉ), hydroxyl radicals (•OH), nitric oxide (•NO),
hydrogen peroxide (H2O2) and other powerful mutagenic reactive ni-
trogen species as a direct result of the presence of fecal bacteria and
bile pigments [48–50]. Under normal conditions, these oxidants are
scavenged efﬁciently, but when their production outstrips antioxi-
dant protection mechanisms (e.g., in inﬂammatory bowel diseases
or ageing), their accumulation could give rise to somatic mutations
and colon cancer.
Important ﬁndings presented here show that, after challenging
Caco-2 cells with the endogenous oxidant H2O2, simultaneous addition
of SFN (6 μM)plus selenite (50 nM) evoked greater cell protection from
H2O2-induced cell injury thanwhen either compoundwas added in iso-
lation. However, apart from inducing the two selenoproteins studied
here, SFN activates many more genes containing an ARE in their pro-
moter region, such as phase II enzymes, redox-active proteins,
GSH-related enzymes and several other novel enzymes recently identi-
ﬁed [51]. Therefore, to investigate whether the protection exerted by
SFN and selenite after H2O2 treatment was driven by TrxR1 and GPx2,
Caco-2 cells were transfected with siRNA to generate a single and dou-
ble knockdown of TrxR1 and/or GPx2. In addition, Nrf2 was knocked
down to identify the role of other Nrf2-dependent/antioxidant genes.
Both TrxR1 and GPx2 substantially contributed to the preservation of
cell integrity after H2O2 treatment. The knockdown of Nrf2 increased
the cell death even further, indicating that more Nrf2 targets, such as
catalase or peroxiredoxins [52], might be involved in the protection.
Increasing understanding of the effect of ITCs and Se on TrxR1 and
GPx2 expression has many implications. For example, previous studies
have supported the opinion that expression of selenoproteins can be
mutually exclusive, as shown by the contrasting expression patterns
of GPx1 and TrxR1 in both human and mouse cells [53], as well as of
GPx2 and GPx3 or selenoprotein P in gastrointestinal cancers [54,55].
However, the results presented here suggest that once these
selenoenzymes have been induced by the coordinated action of the
studied dietary factors they may act in concert under oxidative stress
conditions (regardless of their selenoprotein hierarchy) to maintain or
re-establish the aberrant intracellular redox environment present in
cancer cells. This has important implications for the treatment of cancer
as cells may acquire growth advantage indicated by an enhanced ROS
detoxiﬁcation due to an additional Nrf2 and/or Nrf2-related genes
(TrxR1 and GPx2) activation that promoted cell proliferation throughdecreased apoptosis. The consequences of enhancingROS detoxiﬁcation
by Nrf2 induction has been recently highlighted by Tuveson and col-
leagues [56]. In recent years, the role that TrxR1 plays in cancer has
become clearer as TrxR1 is highly up-regulated in human tumours
and cancer cell lines [57]. In addition, the fact thatGPx2 is transiently in-
creased in human colorectal adenomas, with the highest expression in
pre-cancerous polyps (adenomas) [55] and reducing amounts in late
stage of carcinogenesis, implies that expression of this selenoprotein
may depend on the developmental stage of malignant transformation
and so may participate in the process of cancer development [58].
Although the protective effect of these selenoproteins in normal
cells is well documented [59,60], this study has shown that addition
of ITC+Se will up-regulate the expression of the aforementioned
genes, providing signals to sustain the cancerous process by
protecting Caco-2 cells from H2O2-induced cell death. However, re-
sults obtained from this research could potentially be translated
into normal cells as shown by Campbell et al. [61] who observed ox-
idative stress protection in normal human endothelial cell line
EAhy926 in a synergistic manner in response to SFN and selenite.
This dual role suggests that cell response to speciﬁc dietary compo-
nents are likely to differ in non-cancerous and cancerous cells, and
will most certainly depend on the cell and/or tissue type, dose and
the chemical form in which dietary constituents are administered.
In summary, ITCs and Se in combination provide colon cancer cells
with the ability to protect themselves from free radical-mediated cell
death effect, which is largely mediated through two selenoproteins,
TrxR1 and GPx2. Over-expression of these selenoproteins is achieved
by increasing mRNA levels by ITCs at the transcriptional level togeth-
er with an adequate level of Se supply to guarantee translational ex-
pression. Further studies are necessary to investigate the impact of a
diet high in cruciferous vegetables and selenium in chemoprevention,
and at different stages of cancer development.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.07.007.
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